BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33212152)

  • 1. Epigenetic Alterations in Keratinocyte Carcinoma.
    Yao Q; Epstein CB; Banskota S; Issner R; Kim Y; Bernstein BE; Pinello L; Asgari MM
    J Invest Dermatol; 2021 May; 141(5):1207-1218. PubMed ID: 33212152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular classification of basal cell carcinoma of skin by gene expression profiling.
    Jee BA; Lim H; Kwon SM; Jo Y; Park MC; Lee IJ; Woo HG
    Mol Carcinog; 2015 Dec; 54(12):1605-12. PubMed ID: 25328065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic alterations in metastatic cutaneous carcinoma.
    Darr OA; Colacino JA; Tang AL; McHugh JB; Bellile EL; Bradford CR; Prince MP; Chepeha DB; Rozek LS; Moyer JS
    Head Neck; 2015 Jul; 37(7):994-1001. PubMed ID: 24700717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases in keratinocyte carcinomas.
    Riihilä P; Nissinen L; Kähäri VM
    Exp Dermatol; 2021 Jan; 30(1):50-61. PubMed ID: 32869366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and environmental factors underlying keratinocyte carcinoma risk.
    Choquet H; Ashrafzadeh S; Kim Y; Asgari MM; Jorgenson E
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32434987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
    Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
    Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic variants of the vitamin D receptor (VDR) with cutaneous squamous cell carcinomas (SCC) and basal cell carcinomas (BCC): a pilot study in a German population.
    Köstner K; Denzer N; Koreng M; Reichrath S; Gräber S; Klein R; Tilgen W; Vogt T; Reichrath J
    Anticancer Res; 2012 Jan; 32(1):327-33. PubMed ID: 22213323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
    Liu-Smith F; Jia J; Zheng Y
    Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XPA, haplotypes, and risk of basal and squamous cell carcinoma.
    Miller KL; Karagas MR; Kraft P; Hunter DJ; Catalano PJ; Byler SH; Nelson HH
    Carcinogenesis; 2006 Aug; 27(8):1670-5. PubMed ID: 16513681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of c-erbB-1 and c-erbB-2 oncogenes in basal cell carcinoma and squamous cell carcinoma of skin.
    Liu B; Zhang H; Li S; Chen W; Li R
    Chin Med Sci J; 1996 Jun; 11(2):106-9. PubMed ID: 9387420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic loss at Drosophila patched gene is highly prevalent in Basal and squamous cell carcinomas of the skin.
    Danaee H; Karagas MR; Kelsey KT; Perry AE; Nelson HH
    J Invest Dermatol; 2006 May; 126(5):1152-8. PubMed ID: 16484983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes.
    Hochberg M; Gilead L; Markel G; Nemlich Y; Feiler Y; Enk CD; Denichenko P; Karni R; Ingber A
    Arch Dermatol Res; 2013 Aug; 305(6):519-28. PubMed ID: 23543219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic changes in Basal Cell Carcinoma affect SHH and WNT signaling components.
    Brinkhuizen T; van den Hurk K; Winnepenninckx VJ; de Hoon JP; van Marion AM; Veeck J; van Engeland M; van Steensel MA
    PLoS One; 2012; 7(12):e51710. PubMed ID: 23284750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAV3 copy number changes and target genes in basal and squamous cell cancers.
    Maliniemi P; Carlsson E; Kaukola A; Ovaska K; Niiranen K; Saksela O; Jeskanen L; Hautaniemi S; Ranki A
    Exp Dermatol; 2011 Nov; 20(11):926-31. PubMed ID: 21995814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
    Liyanage UE; Law MH; Han X; An J; Ong JS; Gharahkhani P; Gordon S; Neale RE; Olsen CM; ; MacGregor S; Whiteman DC
    Hum Mol Genet; 2019 Sep; 28(18):3148-3160. PubMed ID: 31174203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic markers in basal cell carcinoma: universal themes in oncogenesis and tumor stratification? - a short report.
    Rao RC; Chan MP; Andrews CA; Kahana A
    Cell Oncol (Dordr); 2018 Dec; 41(6):693-698. PubMed ID: 30215205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-melanoma Skin Cancer - a Clinicopathological Study of Patients with Basal Cell Carcinoma and Squamous Cell Carcinoma.
    Bartoš V; Kullová M
    Klin Onkol; 2017; 31(1):40-45. PubMed ID: 29488777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
    J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis.
    Kubo Y; Urano Y; Yoshimoto K; Iwahana H; Fukuhara K; Arase S; Itakura M
    J Invest Dermatol; 1994 Apr; 102(4):440-4. PubMed ID: 8151121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light microscopic autoradiographical analysis of [125I]epidermal growth factor binding in basal cell epithelioma and squamous cell carcinoma of the skin.
    Ikeuchi T; Urano Y; Fukuhara K; Nakanishi H; Arase S
    J Dermatol; 1993 Apr; 20(4):219-25. PubMed ID: 8315111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.